These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 16819398

  • 1. Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study.
    Regev A, Guaqueta C, Molina EG, Conrad A, Mishra V, Brantly ML, Torres M, De Medina M, Tzakis AG, Schiff ER.
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S30-5. PubMed ID: 16819398
    [Abstract] [Full Text] [Related]

  • 2. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
    Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Stravitz RT, Mills AS.
    Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
    [Abstract] [Full Text] [Related]

  • 3. Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency.
    Graziadei IW, Joseph JJ, Wiesner RH, Therneau TM, Batts KP, Porayko MK.
    Hepatology; 1998 Oct; 28(4):1058-63. PubMed ID: 9755243
    [Abstract] [Full Text] [Related]

  • 4. alpha1-Antitrypsin deficiency is not an important cause of childhood liver diseases in a multi-ethnic Southeast Asian population.
    Lee WS, Yap SF, Looi LM.
    J Paediatr Child Health; 2007 Sep; 43(9):636-9. PubMed ID: 17688648
    [Abstract] [Full Text] [Related]

  • 5. Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study.
    Serfaty L, Chazouillères O, Poujol-Robert A, Morand-Joubert L, Dubois C, Chrétien Y, Poupon RE, Petit JC, Poupon R.
    Hepatology; 1997 Sep; 26(3):776-9. PubMed ID: 9303512
    [Abstract] [Full Text] [Related]

  • 6. Alpha-1-antitrypsin deficiency in children: liver disease is not reflected by low serum levels of alpha-1-antitrypsin - a study on 48 pediatric patients.
    Lang T, Mühlbauer M, Strobelt M, Weidinger S, Hadorn HB.
    Eur J Med Res; 2005 Dec 07; 10(12):509-14. PubMed ID: 16356865
    [Abstract] [Full Text] [Related]

  • 7. Art, alpha-1-antitrypsin polymorphisms and intense creative energy: blessing or curse?
    Schmechel DE.
    Neurotoxicology; 2007 Sep 07; 28(5):899-914. PubMed ID: 17659342
    [Abstract] [Full Text] [Related]

  • 8. Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis.
    Hodges JR, Millward-Sadler GH, Barbatis C, Wright R.
    N Engl J Med; 1981 Mar 05; 304(10):557-60. PubMed ID: 6969850
    [Abstract] [Full Text] [Related]

  • 9. The prevalence of gallstones in chronic liver disease is related to degree of liver dysfunction.
    Elzouki AN, Nilsson S, Nilsson P, Verbaan H, Simanaitis M, Lindgren S.
    Hepatogastroenterology; 1999 Mar 05; 46(29):2946-50. PubMed ID: 10576378
    [Abstract] [Full Text] [Related]

  • 10. Enhanced phenotypic expression of alpha-1-antitrypsin deficiency in an MZ heterozygote with chronic hepatitis C.
    Banner BF, Karamitsios N, Smith L, Bonkovsky HL.
    Am J Gastroenterol; 1998 Sep 05; 93(9):1541-5. PubMed ID: 9732941
    [Abstract] [Full Text] [Related]

  • 11. Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage.
    Valenti L, Dongiovanni P, Piperno A, Fracanzani AL, Maggioni M, Rametta R, Loria P, Casiraghi MA, Suigo E, Ceriani R, Remondini E, Trombini P, Fargion S.
    Hepatology; 2006 Oct 05; 44(4):857-64. PubMed ID: 17006922
    [Abstract] [Full Text] [Related]

  • 12. alpha 1-antitrypsin phenotype PiMZ, a risk factor for liver cirrhosis but not for liver cancers in Thailand.
    Smanadhikorn P, Pongpaew P, Srivatanakul P, Tungtrongchitr R, Supanaranond W, Schelp FP, Migasena P.
    Southeast Asian J Trop Med Public Health; 1995 Jun 05; 26(2):240-2. PubMed ID: 8629052
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients.
    Lemos LB, Perez RM, Lemos MM, Draibe SA, Silva IS, Silva AE, Ferraz ML.
    Nephron Clin Pract; 2008 Jun 05; 108(2):c135-40. PubMed ID: 18230916
    [Abstract] [Full Text] [Related]

  • 14. Alpha 1-antitrypsin granules in the liver--always important?
    Brind AM, Bassendine MF, Bennett MK, James OF.
    Q J Med; 1990 Jul 05; 76(279):699-709. PubMed ID: 2217674
    [Abstract] [Full Text] [Related]

  • 15. Variable degree of liver involvement in siblings with PiZZ alpha-1-antitrypsin deficiency-related liver disease.
    Hinds R, Hadchouel A, Shanmugham NP, Al-Hussaini A, Chambers S, Cheeseman P, Mieli-Vergani G, Hadzić N.
    J Pediatr Gastroenterol Nutr; 2006 Jul 05; 43(1):136-8. PubMed ID: 16819392
    [Abstract] [Full Text] [Related]

  • 16. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD).
    Madan K, Bhardwaj P, Thareja S, Gupta SD, Saraya A.
    J Clin Gastroenterol; 2006 Jul 05; 40(10):930-5. PubMed ID: 17063114
    [Abstract] [Full Text] [Related]

  • 17. Population genetic screening for alpha1-antitrypsin deficiency in a high-prevalence area.
    Corda L, Medicina D, La Piana GE, Bertella E, Moretti G, Bianchi L, Pinelli V, Savoldi G, Baiardi P, Facchetti F, Gatta N, Annesi-Maesano I, Balbi B.
    Respiration; 2011 Jul 05; 82(5):418-25. PubMed ID: 21474916
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.
    Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S.
    Hepatology; 2005 Jul 05; 42(1):44-52. PubMed ID: 15895401
    [Abstract] [Full Text] [Related]

  • 19. Association of α 1 Antitrypsin Phenotype and Development of Advanced Liver Disease and Pulmonary Complications Before and After Liver Transplantation.
    Abu Rmilah A, Fencl R, Watt K, Krowka M, Wiesner R, Murray D, Nyberg S, Leise M.
    Transplantation; 2021 Jul 01; 105(7):1576-1584. PubMed ID: 32732616
    [Abstract] [Full Text] [Related]

  • 20. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR, Bhan AK, Zheng H, Chung RT.
    Cancer; 2007 Jun 15; 109(12):2490-6. PubMed ID: 17487861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.